Champions Oncology Inc (CSBR)
Champions Oncology, Inc. is a healthcare company listed on the NASDAQ under the ticker CSBR. The company focuses on technology-enabled research services for drug discovery and development, with a primary emphasis on oncology. Its Tumorgraft platform supports personalized cancer care by using human tumor implantation in immune-deficient mice, while its translational oncology services are designed to aid pharmaceutical and biotechnology clients in the research stages of drug development. Champions Oncology also provides Lumin Bioinformatics, a software product that organizes oncology data from research services and clinical studies. The company markets its solutions through internet channels and a sales force. Founded in 1985 and headquartered in Hackensack, New Jersey, it previously operated under the name Champions Biotechnology, Inc., before adopting its current name in 2011.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CSBR
|
$5.70
|
-6.6% Downside
|
Fair
|
$12
|
96.7% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
July 21, 2026
|
-36.2x
|
19.8x
|
1.5x
|
84.71 M
|
82.677 M
|
5.6%
|
43.7%
|
-0.1
|
—
|
-162.9%
|
